These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5523395)

  • 41. Indocyanine green clearance test for screening liver function in normal and pre-eclamptic women.
    Mati JK; Kahuho S; Horrobin DF
    East Afr Med J; 1973 Mar; 50(3):132-5. PubMed ID: 4724675
    [No Abstract]   [Full Text] [Related]  

  • 42. [Specific liver function: liver volume as reference parameter of the function].
    Halpern A; Bircher J; Tauber J; Blankart R; Rösler H; Preisig R
    Schweiz Med Wochenschr; 1971 May; 101(20):736-7. PubMed ID: 5578403
    [No Abstract]   [Full Text] [Related]  

  • 43. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.
    Villeneuve JP; Huot R; Marleau D; Huet PM
    Am J Gastroenterol; 1982 Apr; 77(4):233-7. PubMed ID: 7072694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interpretation of indocyanine green test in comparison with bromsulphthalein].
    Namihisa T; Nanbu M
    Nihon Rinsho; 1976; 34 suppl():1971-87. PubMed ID: 792499
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnostic value of the wofaverdin test].
    Sensing H; Zabel-Langhennig R; Köhler P; Scholtze P
    Dtsch Gesundheitsw; 1972 Oct; 27(43):2046-9. PubMed ID: 5087013
    [No Abstract]   [Full Text] [Related]  

  • 46. Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.
    Marmo R; Romano M; de Sio I; Peduto A; Caporaso N; Persico M; Coltorti M
    Ital J Gastroenterol; 1993 Jan; 25(1):1-8. PubMed ID: 8428017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimation of degree of liver cirrhosis using a fibrosis score; a multivariate analysis of clinical parameters and resected specimens.
    Shimada M; Matsumata T; Adachi E; Itasaka H; Watiyama S; Sugimachi K
    Hepatogastroenterology; 1994 Apr; 41(2):177-80. PubMed ID: 8056410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary study of indocyanine green clearance in primary biliary cirrhosis.
    Clements D; Elias E; McMaster P
    Scand J Gastroenterol; 1991 Jan; 26(1):119-23. PubMed ID: 2006392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Granulomatous hepatitis. A review of 50 cases.
    Mir-Madjlessi SH; Farmer RG; Hawk WA
    Am J Gastroenterol; 1973 Aug; 60(2):122-34. PubMed ID: 4741106
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hepatic function related to the ICG test--evaluation by using principle component analysis and multiple regression analysis].
    Shirata T; Wada Y; Watanabe H; Miyazawa K; Shinzawa H
    Rinsho Byori; 1985 Mar; 33(3):330-4. PubMed ID: 4010005
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of the liver function by the indocyanine green test after various forms of viral hepatitis].
    Sowa J; Skawińska Z
    Przegl Epidemiol; 1972; 26(1):147-50. PubMed ID: 5028832
    [No Abstract]   [Full Text] [Related]  

  • 52. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indocyanine green test in the diagnosis of hepatocellular damage].
    Caban M
    Pol Tyg Lek; 1977 Nov; 32(48):1901-3. PubMed ID: 593963
    [No Abstract]   [Full Text] [Related]  

  • 54. [1st experiences with the indocyanine green (Wofaverdine) test as a liver function test].
    Reuter E; Jorke D
    Z Gesamte Inn Med; 1966 Aug; 21(15):Suppl:180-2. PubMed ID: 5990889
    [No Abstract]   [Full Text] [Related]  

  • 55. [What is the onset of primary biliary liver cirrhosis?].
    Linhart P; Börner N; Leiss O
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():94-5. PubMed ID: 7483729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure.
    de Liguori Carino N; O'Reilly DA; Dajani K; Ghaneh P; Poston GJ; Wu AV
    Eur J Surg Oncol; 2009 Sep; 35(9):957-62. PubMed ID: 19250796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis.
    Iwata T; Inoue K; Nishiyama N; Nagano K; Izumi N; Tsukioka T; Hanada S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):720-30. PubMed ID: 17766277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Indocyanine green test in liver diseases with jaundice].
    Matuszak J; Tkaczewski W; Karasek E
    Wiad Lek; 1972 May; 25(10):883-8. PubMed ID: 5029354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.